BR

Bairavan Ramasamy Chettiar

Active Director Director DIN 02710847
DIN 02710847 First appointment Sep 1990 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 1990
Shareholding value β€’β€’β€’β€’ Premium profile

About Bairavan Ramasamy Chettiar

Data last updated:

Bairavan Ramasamy Chettiar is a Director at Meirs Pharma (India) Private Limited (since 1990). The company operates in Healthcare.

DIN 02710847
Primary Designation Director
Industry Healthcare
First Appointment 05 Sep 1990
Oldest Company Age 41 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meirs Pharma (India) Private Limited U24305PY1985PTC000311
Director05 Sep 19901985Active

Board colleagues of Bairavan Ramasamy Chettiar

Directorship timeline

Open interactive timeline →
Meirs Pharma (India) Private Limited
Premium access

Shareholding and investment profile for Bairavan Ramasamy Chettiar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bairavan Ramasamy Chettiar

Bairavan Ramasamy Chettiar currently holds 1 directorship: Meirs Pharma (India) Private Limited (Director, since 05 Sep 1990).

Bairavan Ramasamy Chettiar was first appointed on 05 Sep 1990 as Director at Meirs Pharma (India) Private Limited.

The current boards of Bairavan Ramasamy Chettiar's companies include Arunachalam Kannappan (Meirs Pharma (India) Private Limited), Bhupendra Kumar Nirula (Meirs Pharma (India) Private Limited), Ramaswamy Bairavan (Meirs Pharma (India) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available